4.7 Article

Angiotensin II Modulates Calcium/Phosphate Excretion in Experimental Model of Hypertension: Focus on Bone

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions

D. Canoy et al.

Summary: There are commonalities in the physiologic regulation of blood pressure and bone metabolism, with certain classes of antihypertensive drugs potentially affecting bone mineral density. Current evidence is insufficient to establish causal associations between blood pressure, blood pressure-lowering drugs, and bone health outcomes like osteoporosis and fractures. Advancements in study designs and analytical approaches provide opportunities for more detailed and reliable examination of the relationship between blood pressure and bone health. It is important to consider the strengths and limitations of different data sources and analytical techniques in order to advance our understanding of the impact of elevated blood pressure and its drug treatment on bone health outcomes.

OSTEOPOROSIS INTERNATIONAL (2022)

Article Peripheral Vascular Disease

NLRP3 inflammasome contributes to endothelial dysfunction in angiotensin II-induced hypertension in mice

Xingbing Li et al.

MICROVASCULAR RESEARCH (2022)

Review Endocrinology & Metabolism

PTH, FGF-23, Klotho and Vitamin D as regulators of calcium and phosphorus: Genetics, epigenetics and beyond

Ignacio Portales-Castillo et al.

Summary: Bone-mineral ion regulators, such as PTH, FGF23, Klotho, and 1,25(OH)2 vitamin D, play important roles in calcium and phosphate metabolism and cell signaling. These factors are tightly regulated through genetic, epigenetic, and post-translational mechanisms. Epigenetic mechanisms, including DNA methylation and histone modification, have been found to affect the function of these regulators.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Cell & Tissue Engineering

GsαR201C and estrogen reveal different subsets of bone marrow adiponectin expressing osteogenic cells

Biagio Palmisano et al.

Summary: The Gs alpha/cAMP signaling pathway plays a crucial role in regulating the homeostasis of the post-natal skeleton. Dysregulated activity of Gs alpha due to gain-of-function mutations can cause severe disruptions in bone architecture and function. This study provides evidence that the Adq-cell network not only regulates bone resorption but also contributes to bone formation, and that the Gs alpha/cAMP pathway is a key regulator of both functions.

BONE RESEARCH (2022)

Article Biochemistry & Molecular Biology

Angiotensin Type 2 and Mas Receptor Activation Prevents Myocardial Fibrosis and Hypertrophy through the Reduction of Inflammatory Cell Infiltration and Local Sympathetic Activity in Angiotensin II-Dependent Hypertension

Giovanna Castoldi et al.

Summary: The study showed that activation of AT2 or Mas receptors can prevent myocardial fibrosis and hypertrophy in an angiotensin II-dependent hypertension model, reducing myocardial inflammatory cell infiltration and sympathetic nervous system activity.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Endocrinology & Metabolism

Sodium-glucose cotransporter 2 inhibition prevents renal fibrosis in cyclosporine nephropathy

Giovanna Castoldi et al.

Summary: Empagliflozin administration reduces blood pressure in rats with cyclosporine nephropathy and protects against renal fibrosis, collagen expression, inflammatory infiltration, and sympathetic nerve activity, suggesting nephroprotection in non-diabetic kidney disease.

ACTA DIABETOLOGICA (2021)

Article Physiology

Aldosterone Is Positively Associated With Circulating FGF23 Levels in Chronic Kidney Disease Across Four Species, and May Drive FGF23 Secretion Directly

Judith Radloff et al.

Summary: The study demonstrated a strong positive association between circulating intact FGF23 and serum aldosterone in human, canine, and feline CKD patients, as well as in experimental murine CKD models. Acute injection of canrenone did not lead to changes in FGF23 levels within 24 hours, but reduced FGF23 in all mice at 72 hours, suggesting that aldosterone may drive enhanced FGF23 secretion in CKD.

FRONTIERS IN PHYSIOLOGY (2021)

Article Cardiac & Cardiovascular Systems

The renin-angiotensin-aldosterone system: a crossroad from arterial hypertension to heart failure

Nicola Riccardo Pugliese et al.

HEART FAILURE REVIEWS (2020)

Article Biochemistry & Molecular Biology

Effect of Angiotensin II on Bone Erosion and Systemic Bone Loss in Mice with Tumor Necrosis Factor-Mediated Arthritis

Takahiko Akagi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Endocrinology & Metabolism

Activation of angiotensin type 2 (AT2) receptors prevents myocardial hypertrophy in Zucker diabetic fatty rats

Giovanna Castoldi et al.

ACTA DIABETOLOGICA (2019)

Review Physiology

ANGIOTENSIN II SIGNAL TRANSDUCTION: AN UPDATE ON MECHANISMS OF PHYSIOLOGY AND PATHOPHYSIOLOGY

Steven J. Forrester et al.

PHYSIOLOGICAL REVIEWS (2018)

Article Biochemistry & Molecular Biology

Crosstalk between FGF23-and angiotensin II-mediated Ca2+ signaling in pathological cardiac hypertrophy

Ketaki N. Mhatre et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2018)

Article Physiology

In vivo evidence for an interplay of FGF23/Klotho/PTH axis on the phosphate handling in renal proximal tubules

Noriko Ide et al.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)

Article Pharmacology & Pharmacy

The ACE-2/Ang1-7/Mas cascade enhances bone structure and metabolism following angiotensin-II type 1 receptor blockade

Hatem M. Abuohashish et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2017)

Article Biochemistry & Molecular Biology

Up-regulation of FGF23 release by aldosterone

Bingbing Zhang et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)

Article Pharmacology & Pharmacy

Different regulation of miR-29a-3p in glomeruli and tubules in an experimental model of angiotensin II-dependent hypertension: potential role in renal fibrosis

Giovanna Castoldi et al.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2016)

Article Cardiac & Cardiovascular Systems

Hypertension Renin-Angiotensin-Aldosterone System Alterations

Luuk te Riet et al.

CIRCULATION RESEARCH (2015)

Article Cardiac & Cardiovascular Systems

Activation of the cardiac proteasome promotes angiotension II-induced hypertrophy by down-regulation of ATRAP

Nan Li et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)

Article Endocrinology & Metabolism

Molecular Mechanisms of Vascular Calcification in Chronic Kidney Disease: The Link between Bone and the Vasculature

Chang Hyun Byon et al.

CURRENT OSTEOPOROSIS REPORTS (2015)

Article Endocrinology & Metabolism

Hypertension, Antihypertensive Drugs and the Risk of Fractures

Debra A. Butt et al.

CLINICAL REVIEWS IN BONE AND MINERAL METABOLISM (2015)

Article Immunology

The immune system and hypertension

Madhu V. Singh et al.

IMMUNOLOGIC RESEARCH (2014)

Article Endocrinology & Metabolism

Effects of angiotensin-converting enzyme inhibitor, captopril, on bone of mice with streptozotocin-induced type 1 diabetes

Teng-Yue Diao et al.

JOURNAL OF BONE AND MINERAL METABOLISM (2014)

Article Endocrinology & Metabolism

A High Aldosterone to Renin Ratio Is Associated With High Serum Parathyroid Hormone Concentrations in the General Population

Evelyn Fischer et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)

Review Endocrinology & Metabolism

The Relationship Among Hypertension, Antihypertensive Medications, and Osteoporosis: A Narrative Review

Katarina Ilic et al.

CALCIFIED TISSUE INTERNATIONAL (2013)

Article Biochemistry & Molecular Biology

Involvement of the Skeletal Renin-Angiotensin System in Age-Related Osteoporosis of Ageing Mice

Sa-sa Gu et al.

BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2012)

Article Urology & Nephrology

Influence of renin-angiotensin system on serum parathyroid hormone levels in uremic patients

Fumihiko Koiwa et al.

CLINICAL AND EXPERIMENTAL NEPHROLOGY (2012)

Article Endocrinology & Metabolism

Physiological Function of the Angiotensin AT1a Receptor in Bone Remodeling

Keiko Kaneko et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2011)

Article Physiology

Soft Bone - Hard Arteries: A Link?

Gerard M. London

KIDNEY & BLOOD PRESSURE RESEARCH (2011)

Article Endocrinology & Metabolism

Activation of Renin-Angiotensin System Induces Osteoporosis Independently of Hypertension

Yutaro Asaba et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2009)

Article Biochemistry & Molecular Biology

Angiotensin II accelerates osteoporosis by activating osteoclasts

Hideo Shimizu et al.

FASEB JOURNAL (2008)

Review Physiology

Physiology of local renin-angiotensin systems

Martin Paul et al.

PHYSIOLOGICAL REVIEWS (2006)

Article Biochemistry & Molecular Biology

Effects of angiotensin II on NaPi-IIa co-transporter expression and activity in rat renal cortex

LP Xu et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2004)

Article Multidisciplinary Sciences

Calcification in atherosclerosis: Bone biology and chronic inflammation at the arterial crossroads

TM Doherty et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)